Real-time enrollment status for this breast cancer clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 3:49 AM UTC
| NCT Number | NCT06686394 |
| Recruiting Status | Recruiting |
| Condition | Breast Cancer |
| Phase | PHASE1 |
| Target Enrollment | 81 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | May 22, 2026 (May 22, 2026) |
As of July 20, 2026: Clinical trial NCT06686394 is currently recruiting participants. This phase1 study for breast cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06686394 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06686394 was last updated May 22, 2026 (May 22, 2026). HelloStudys verifies this status automatically.